Trillium Therapeutic (TRIL) Stock Price, Quote, News and Overview

What is the stock price of Trillium Therapeutic today?

The current stock price of TRIL is 18.44 null. The price increased by 2.62% in the last trading session.

What is the ticker symbol for Trillium Therapeutic stock?

The exchange symbol of Trillium Therapeutic is TRIL and it is listed on the Nasdaq exchange.

On which exchange is TRIL stock listed?

TRIL stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for Trillium Therapeutic stock?

10 analysts have analysed TRIL and the average price target is 15.2 null. This implies a price decrease of -17.59% is expected in the next year compared to the current price of 18.44. Check the Trillium Therapeutic stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is Trillium Therapeutic worth?

Trillium Therapeutic (TRIL) has a market capitalization of 1.93B null. This makes TRIL a Small Cap stock.

How many employees does Trillium Therapeutic have?

Trillium Therapeutic (TRIL) currently has 33 employees.

What are the support and resistance levels for Trillium Therapeutic (TRIL) stock?

Trillium Therapeutic (TRIL) has a support level at 17.92. Check the full technical report for a detailed analysis of TRIL support and resistance levels.

Is Trillium Therapeutic (TRIL) expected to grow?

The Revenue of Trillium Therapeutic (TRIL) is expected to decline by -96.9% in the next year. Check the estimates tab for more information on the TRIL EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy Trillium Therapeutic (TRIL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of TRIL, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of TRIL, evaluating the profitability, health, valuation and growth aspects
• Trillium Therapeutic (TRIL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• Trillium Therapeutic (TRIL) Sales and EPS estimates to see what analysts future expectations are.
• Trillium Therapeutic (TRIL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• Trillium Therapeutic (TRIL) Insider and Institutional Ownership to learn about the owners and their transactions.
• Trillium Therapeutic (TRIL) Stock Chart to make your own analysis
• Trillium Therapeutic (TRIL) Latest news and press-releases to stay up to date.

Does Trillium Therapeutic (TRIL) stock pay dividends?

TRIL does not pay a dividend.

When does Trillium Therapeutic (TRIL) report earnings?

Trillium Therapeutic (TRIL) will report earnings on 2022-03-17, after the market close.

What is the Price/Earnings (PE) ratio of Trillium Therapeutic (TRIL)?

Trillium Therapeutic (TRIL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.79).

ChartMill assigns a fundamental rating of 3 / 10 to TRIL. No worries on liquidiy or solvency for TRIL as it has an excellent financial health rating, but there are worries on the profitability.

Over the last trailing twelve months TRIL reported a non-GAAP Earnings per Share(EPS) of -0.79. The EPS increased by 52.93% compared to the year before.

ChartMill assigns a Buy % Consensus number of 78% to TRIL. The Buy consensus is the average rating of analysts ratings from 10 analysts.

For the next year, analysts expect an EPS growth of -9.05% and a revenue growth -96.9% for TRIL